N-Desmethyl Clozapine
Product Code
TRC-D292000
CAS Number
EP Description
Clozapine Impurity C
USP Description
Clozapine Impurity C
Product Format
Neat
Molecular Formula
C17 H17 Cl N4
Molecular Weight
312.80
API Family
ClozapineProduct Categories
TRC, Antipsychotics, Benzodiazepines Reference Materials , Agonist & antagonist analogues, Impurity Reference Materials , Acetylcholine Receptors, Neurotransmission, Memory, Learning and Cognition, Parkinson's, Schizophrenia, Pain and Inflammation
Product Type
MetabolitePurity
>95% (HPLC)
Documentation
Looking for another lot?
To view all certificates of analysis immediately, please login to your account
or
{{ errors.first('lotNumber') }}
{{ errors.first('requestEmail') }}
For information about our data processing activities, please visit our Privacy Notice.
Enter your email address and we'll email you the relevant CoA for lots:
{{ coaPopupData.packSize.coaSelectedLotNumbers }}
{{ errors.first('coaEmail') }}
We will be sending the CoA to your email address {{ coaEmailPopupData.userEmail }}
Your request has been sent to our sales team to process.
Find an SDS for your region
{{ errors.first('selectedRegion') }}
{{ errors.first('sdsEmail') }}
For information about our data processing activities, please visit our Privacy Notice.
Your request has been sent to our sales team to process.
Product Information
Chemical Data
Analyte Name
N-Desmethylclozapine
CAS Number
6104-71-8
Molecular Formula
C17 H17 Cl N4
Molecular Weight
312.80
Accurate Mass
312.1142
SMILES
Clc1ccc2Nc3ccccc3C(=Nc2c1)N4CCNCC4
InChI
InChI=1S/C17H17ClN4/c18-12-5-6-15-16(11-12)21-17(22-9-7-19-8-10-22)13-3-1-2-4-14(13)20-15/h1-6,11,19-20H,7-10H2
IUPAC
3-chloro-6-piperazin-1-yl-11H-benzo[b][1,4]benzodiazepine
Product Data
Storage Temperature
-20°C
Shipping Temperature
Room Temperature
Country of Origin
CANADA
Product Type
Metabolite
Product Format
Neat
API Family
Purity
>95% (HPLC)
Product Description
N-Desmethyl Clozapine is a metabolite of Clozapine (C587500). N-Desmethyl Clozapine is a potent, allosteric agonist at human M1 receptors and is able to potentiate hippocampal NMDA receptor currents through M1 receptor activation.
References: Sur, C., et al.: Proc. Nat. Acad. Sci. U. S. A., 100, 13674 (2003); Kuoppamaki, M. et al.: Eur. J. Pharm. Mol. Pharm. Sect., 245, 179 (1993); Olessen, O.V., et al.: J. Chromatog., 622, 39 (1993); Pirmohamed, M., et al.: J. Pharmacol. Exp. Ther., 272, 984 (1995)